CN1061882C - Effective medicine for treating apoplexy - Google Patents
Effective medicine for treating apoplexy Download PDFInfo
- Publication number
- CN1061882C CN1061882C CN97110677A CN97110677A CN1061882C CN 1061882 C CN1061882 C CN 1061882C CN 97110677 A CN97110677 A CN 97110677A CN 97110677 A CN97110677 A CN 97110677A CN 1061882 C CN1061882 C CN 1061882C
- Authority
- CN
- China
- Prior art keywords
- apoplexy
- chinese medicine
- traditional chinese
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine for treating apoplexy diseases, which is called apoplexy xueshen. Each dose of the traditional Chinese medicine is prepared from the following components of 15 to 30g of wine-fried Chinese angelica, 10 to 30g of hemlock parsley, 15 to 25g of scorpion, 5 to 15g of safflower, 5 to 20g of parsnip, 10 to 30g of stir-fried big head atractylodes rhizome, 6 to 15g of rehmanniae praeparatum, 6 to 20g of batryticated silkworm, 3 to 8g of centipede, 45 to 60g of raw abalone shell, 6 to 30g of medicinal cyathula root, 6 to 30g of plantain seed, 3 to 15g of glycyrrhiza, 30 to 60 ml of bamboo sap and 6 to 20g of uncaria. The traditional Chinese medicine has the advantages that the traditional Chinese medicine is effective on both cerebral hemorrhage apoplexy and cerebral ischemia apoplexy, and is especially suitable for the mixing apoplexy that hemorrhage apoplexy and cerebral ischemia apoplexy exist together; besides, the traditional Chinese medicine is suitable for senile dementia and the diseases of the heart, the cerebra and the blood vessels. The traditional Chinese medicine has a high curative effect with the cure rate of more than 96% and a short treatment course of 1 to 3 months.
Description
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine that is used for the treatment of the apoplexy disease.
Apoplexy is a big disease that jeopardizes human life's safety.It is existing many now to be used for the treatment of this sick Chinese medicine, as DAHUOLUO DAN, cure mainly apoplexy and hemiplegia, waist lower limb heavy, bend and stretch diseases such as difficulty, rheumatalgia.Restorative bolus: cure mainly apoplexy facial hemiparalysis, hemiplegia, numb hand and foot, muscles and bones is unable, walking is difficult; And control diseases such as anemofrigid-damp arthralgia, bones and muscles pain.Search the wind ball: it is meciless to cure mainly extremity, soft unable, the wind of hemiplegia, facial hemiparalysis, quadriplegia, sufficient knee joint paralysis, limb is painful disease such as itch.ZHONGFENG HUICHUN WAN: cure mainly cerebral infarction, as cerebral thrombosis, cerebral infarction, to sequela such as hemiplegia, the quadriplegia of hemorrhagic apoplexy, limbs are tetanic, stiff tongue is tongue-tied, vertigo, numb limbs and tense tendons etc. have certain curative effect.
Though above-mentioned Chinese medicine has certain curative effect to the apoplexy disease, insufficiently be, the curative effect rate is not high, and general effective percentage is at 60-80%; The course of treatment, length was generally 6-12 month, and only was the treatment to an aspect of apoplexy disease.Be divided into hemorrhagic and cerebral infarction two big classes or roughly be divided into middle internal organs class and apoplex involving the channels and collaterals class accordingly as apoplexy.To the Combination apoplexy, i.e. hemorrhagic apoplexy and cerebral infarction and the patient that deposits, said medicine just can not be treated effectively.If the mutual inhibition or opposite phenomenon then appear in two kinds of medicament while and usefulness at different aspect easily, curative effect reduces or is of no curative effect.
The objective of the invention is to propose a kind ofly can treat hemorrhagic apoplexy (relatively in internal organs), also can treat cerebral infarction (apoplex involving the channels and collaterals relatively), especially the Combination apoplexy is had curative effect, and short treating period, Chinese medicine-Effective medicine for treating apoplexy that curative effect is high.
Can realize purpose of the present invention by following scheme, a kind of Chinese medicine for the treatment of the apoplexy disease is characterized in that this medicine made by following component:
Radix Angelicae Sinensis (processed with wine) 15-30g Rhizoma Chuanxiong 10-30g
Scorpio 15-25g Flos Carthami 5-10g
Radix Saposhnikoviae 5-20g Rhizoma Atractylodis Macrocephalae (parched) 10-30g
Radix Rehmanniae 6-15g reins silkworm 6-20g
Scolopendra 3--8g Concha Haliotidis 45-60g
Radix Cyathulae 6-30g Semen Plantaginis 6-30g
Radix Glycyrrhizae 3-15g Ramulus Uncariae Cum Uncis 6-20g
Succus Bambusae 30-60m1
On the basis of above-mentioned medicament,, add Gypsum Fibrosum 90-150g in every dose of medicine to hemorrhagic apoplexy (internal organs relatively).In order to remove positive yin channel steam and and medicament in other component compatibility, after treatment.To cerebral infarction (apoplex involving the channels and collaterals relatively), add Radix Paeoniae Rubra 10--30g in every dose of medicine in order to invigorating blood circulation.
The function of each component is in this medicament: Radix Angelicae Sinensis: blood circulation promoting and blood stasis dispelling, pain-alleviating and network vessel-freeing.Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.Radix Saposhnikoviae: diaphoresis, pain relieving and spasmolytic.Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.The Rhizoma Atractylodis Macrocephalae: drying damp and strengthening spleen, diuretic is swollen clearly, expectorant water, stopping leak rush down.The Radix Rehmanniae: heat clearing away, removing heat from blood, blood stasis dispelling blood, tissue regeneration promoting blood, beneficial marrow.Concha Haliotidis: the cool liver of tool, town's liver YANG hyperactivity suppressing, make eye bright, suffer from the effect of wind, diuresis.Radix Cyathulae: blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards.Semen Plantaginis: diuretic, heat clearing away, make eye bright, eliminate the phlegm.Scorpio: dispel the wind, pain relieving, collateral dredging, detoxifcation.Scolopendra: detoxifcation, eliminating stagnation, removing obstruction in the collateral to relieve pain, relieving spasm by subduing liver-wind.Reins silkworm: dispel the wind, spasmolytic, pain relieving, drying dampness to eliminate phlegm, detoxicating and resolving stagnation of pathogens.Radix Glycyrrhizae: be in harmonious proportion hundred medicines, separate all toxicity.Ramulus Uncariae Cum Uncis: the heat clearing away suppressing the hyperactive liver, arresting convulsion relieves dizziness, high fever, infantile convulsions, epilepsy, etc.Succus Bambusae: cool liver, relieve dizziness, high fever, infantile convulsions, epilepsy, etc., removing heat-phlegm, relaxing muscles and tendons and activating QI and blood in the collateral.Radix Paeoniae Rubra: clots absorbing, pain relieving, removing heat from blood.Gypsum Fibrosum: clearing away heat-fire, relieving restlessness are quenched the thirst.
This medicine had following effect through 12 years to 793 routine apoplexy human therapies, saw the following form:
| Sick type | Stadium | Case load | Recovery from illness | Produce effects | Take a turn for the better | Invalid | Showing more, % leads | Total effective rate % | ||||||
| The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | |||||||
| Middle internal organs | Tendency | 6 | 6 | 100 | 100 | 100 | ||||||||
| Just | 188 | 72 | 38.3 | 70 | 37.2 | 37 | 19.6 | 9 | 4.8 | 75.4 | 95.2 | |||
| In | 79 | 28 | 35.4 | 41 | 51．9 | 8 | 10.1 | 2 | 2.5 | 87.3 | 97.5 | |||
| After | 154 | 10 | 6.5 | 48 | 31．2 | 90 | 58.4 | 5 | 3.2 | 37.7 | 96.8 | |||
| Subtotal | 427 | 116 | 27.2 | 159 | 37.2 | 135 | 31． 6 | 17 | 4 | 64.4 | 96 | |||
| Apoplex involving the channels and collaterals | Tendency | 22 | 22 | 100 | 100 | 100 | ||||||||
| Just | 131 | 50 | 38.2 | 61 | 46.6 | 20 | 15.3 | 0 | 0 | 84.7 | 100 | |||
| In | 56 | 21 | 37.5 | 24 | 42.9 | 11 | 19.6 | 0 | 0 | 80.4 | 100 | |||
| After | 157 | 14 | 8.9 | 47 | 29 | 92 | 58.6 | 4 | 2.5 | 38.9 | 97.5 | |||
| Subtotal | 366 | 107 | 29.2 | 132 | 36.1 | 123 | 33.6 | 4 | 1．1 | 65.3 | 98.9 | |||
The numeral of statistics from table, its effective percentage of curative effect of this medicament centering internal organs class (relatively hemorrhagic) apoplexy (cure rate+show more rate+improvement rate) is 96%, is 98.9% to its effective percentage of curative effect of apoplex involving the channels and collaterals class (ischemic relatively) apoplexy.To Combination apoplexy (this table is not listed separately), 67 examples are arranged, its effective percentage is 97.5%.In addition, its course of treatment within one month 47.6%, 19.1% between 25.1%, two to three months between from January to February account for 8.2% greater than trimestral.To 100% of tendency apoplexy curative effect, has the effect of prevention of stroke well.This medicament also is applicable to alzheimer disease, the hearts such as apoplexy, brain, angiopathy that scheming infarction causes.
Effect of the present invention is:
1, effective percentage is more than 96%, apparently higher than the level of existing its effective percentage of curative effect at 60-80%.
2, evident in efficacy to the Combination apoplexy.
3, the course of treatment three months with interior be 91.8, be significantly shorter than 6-12 month existing course of treatment.
4, has the very effect of the prevention of stroke of limit.
5, adaptability is wider.
Set forth below in conjunction with embodiment step when of the present invention:
Example 1: its component constitutes
Radix Angelicae Sinensis (processed with wine) 15g Rhizoma Atractylodis Macrocephalae (parched) 1Og Radix Cyathulae 6g
Radix Saposhnikoviae 5g Concha Haliotidis 45g Succus Bambusae 30ml
Scolopendra 3g Ramulus Uncariae Cum Uncis 6g Flos Carthami 5g
Radix Glycyrrhizae 3g Scorpio 15g Bombyx Batryticatus 6g
Rhizoma Chuanxiong 10g Radix Rehmanniae 6g Semen Plantaginis 6g
On above-mentioned medicament basis, middle internal organs class disease adds Gypsum Fibrosum 90g meridians class disease and adds Radix Paeoniae Rubra 10g.
This medicament at the state of an illness than the lighter.
Example 2: its component constitutes
Radix Angelicae Sinensis (processed with wine) 30g Rhizoma Atractylodis Macrocephalae (parched) 30g Radix Cyathulae 30g
Radix Saposhnikoviae 20g Concha Haliotidis 60g Succus Bambusae 60ml
Scolopendra 8g Ramulus Uncariae Cum Uncis 20g Flos Carthami 10g
Radix Glycyrrhizae 15g Scorpio 25g Bombyx Batryticatus 20g
Rhizoma Chuanxiong 30g Radix Rehmanniae 15g Semen Plantaginis 30g
On above-mentioned medicament basis, middle internal organs disease adds Gypsum Fibrosum 150g apoplex involving the channels and collaterals disease and adds Radix Paeoniae Rubra 30g.
This medicament is at the heavier person of the state of an illness.
Example 3: its component constitutes
Radix Angelicae Sinensis (processed with wine) 25g Rhizoma Atractylodis Macrocephalae (parched) 21g Radix Cyathulae 18g
Radix Saposhnikoviae 13g Concha Haliotidis 52g Succus Bambusae 45ml
Scolopendra 5g Ramulus Uncariae Cum Uncis 13g Flos Carthami 7g
Radix Glycyrrhizae 9g Scorpio 20g Bombyx Batryticatus 13g
Rhizoma Chuanxiong 21g Radix Rehmanniae 10g Semen Plantaginis 18g
On above-mentioned medicament basis, middle internal organs disease adds Gypsum Fibrosum 80g apoplex involving the channels and collaterals disease and adds Radix Paeoniae Rubra 20g.
This medicament is at the medium person of the state of an illness.
This medicament can be fried in shallow oil the water clothes also can make Chinese patent medicine forms such as pill, tablet.Instructions about how to take medicine are potion every day, divide the secondary clothes, and afternoon is during 3-5 and service once during 7-9 evening.
The property sent out thing and hot things such as period in a medicine taboo Fructus Capsici, beef, Carnis Canitis, Carnis caprae seu ovis, Equus caballus (L.), Hypophthalmichthys molitrix, chicken, each hatching egg, shrimp, dried mushroom, Sanguis sus domestica.
Claims (3)
1, a kind of Chinese medicine for the treatment of the apoplexy disease is characterized in that this medicine made by following component:
Radix Angelicae Sinensis (processed with wine) 15-30g
Rhizoma Chuanxiong 10-30g
Scorpio 15-25g
Flos Carthami 5-15g
Radix Saposhnikoviae 5-20g
Rhizoma Atractylodis Macrocephalae (parched) 10-30g
Radix Rehmanniae 6-15g
Bombyx Batryticatus 6-20g
Scolopendra 3-8g
Concha Haliotidis 45-60g
Radix Cyathulae 6-30g
Semen Plantaginis 6-30g
Radix Glycyrrhizae 3-15g
Ramulus Uncariae Cum Uncis 6-20g
Succus Bambusae 30-60ml.
2, by the Chinese medicine of the described kind treatment of claim 1 apoplexy disease, it is characterized in that also comprising in this medicine Gypsum Fibrosum 90-150g.
3, by the described a kind of Chinese medicine for the treatment of the apoplexy disease of claim 1, it is characterized in that also comprising in this medicine Radix Paeoniae Rubra 10-30g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97110677A CN1061882C (en) | 1997-05-29 | 1997-05-29 | Effective medicine for treating apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97110677A CN1061882C (en) | 1997-05-29 | 1997-05-29 | Effective medicine for treating apoplexy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1165694A CN1165694A (en) | 1997-11-26 |
| CN1061882C true CN1061882C (en) | 2001-02-14 |
Family
ID=5171532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97110677A Expired - Fee Related CN1061882C (en) | 1997-05-29 | 1997-05-29 | Effective medicine for treating apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1061882C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005565B1 (en) * | 1999-04-13 | 2005-04-28 | Сайдженик Ко., Лтд. | Composition for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus angelicae containing same |
| CN100453093C (en) * | 2002-07-29 | 2009-01-21 | 邢瑞忠 | Medicine for transient cerebral ischemia attack and its preparation |
| CN101301432B (en) * | 2008-04-03 | 2012-05-09 | 王爱红 | Chinese medicinal composition for treating cerebral hemorrhage |
| CN103071061B (en) * | 2013-01-23 | 2014-01-29 | 刘军 | Medicine for treating cerebrovascular diseases and preparation method of same |
-
1997
- 1997-05-29 CN CN97110677A patent/CN1061882C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1165694A (en) | 1997-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1060960C (en) | Health-care wine with antisenility function | |
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN1285364C (en) | Chinese medicinal composition for treating cervical vertebra disease, lumbar vertebra disease and ischialgia | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN104474092A (en) | Traditional Chinese medicine for treatment of psoriasis | |
| CN1294957C (en) | Ointment for treating spur | |
| CN1061882C (en) | Effective medicine for treating apoplexy | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN103860675A (en) | Composition for treating rheumatoid arthritis | |
| CN1049338C (en) | Medicine "Ganyanfukangling" for curing hepatitis | |
| CN1418696A (en) | Traditional Chinese medicine prepn. for treating cervical vertebra disease | |
| CN1247233C (en) | Chinese medicine for varicose vein | |
| CN101703710A (en) | Chinese medicinal preparation for treating gout | |
| CN104027775A (en) | Traditional Chinese medicine for treating thromboangiitis obliterans | |
| CN1310014A (en) | Lumbago treating Chinese medicine | |
| CN106511671A (en) | Medicinal liquor for treating hyperostosis, rheumatism and gout disease | |
| CN106237125A (en) | The active medicine of wind for Demyelination | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN1111032C (en) | Alopecia treating medicine | |
| CN1088593C (en) | Quick-acting Chinese medicine for treating cirrhosis and its preparing process | |
| CN1106857C (en) | Medicine for dispersing stasis and conditioning tendon | |
| CN1092971C (en) | Chinese medicine for treating rheumatism | |
| CN1122520C (en) | Osteanaphysis capsule for treating femoral head necrosis | |
| CN106581574A (en) | Exercise soft tissue injury treating traditional Chinese medicine and preparation method thereof | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |